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ABSTRACT 
 
Background: Prediabetes is a precursor condition to type 2 diabetes mellitus. Previous 
research and clinical trials have shown that the onset of type 2 diabetes could be delayed 
or prevented through structured life style modifications such as dietary changes, modest 
weight loss and moderate-intensity exercise. This study examines U.S adults of different 
ethnicities that include non-Hispanic white, non-Hispanic black and Mexican Americans 
and whether their awareness of diabetes risk is associated with their participation in 
diabetes risk reduction behavior, a combination of physical activity, weight control and 
fat/calories intake. 
 
Methods: The 2007-2008 National Health and Nutrition Examination Survey, NHANES, 
was used to conduct a cross-sectional study of 4083 U.S. adults who were 20 years old 
and above and were aware of their diabetes risk. The association between the awareness 
of one’s diabetes risk and the adoption of diabetes risk reduction behavior were examined 
in present of other risk factors such as age, gender, ethnicity, education, annual family 
income, BMI, hypertension, mean systolic blood pressure, mean diastolic blood pressure, 
total cholesterol, LDL, HDL and triglyceride levels. Males and females were examined 
separately for all analyses performed. Cross tabulation was conducted and p-values were 
calculated by the Pearson’s chi-square test for the categorical variables which include 
gender, ethnicity, education, annual family income, adiposity and hypertension. One Way 
ANOVA and Tukey post hoc tests were conducted for the continuous variables which 
include age, mean systolic blood pressure, mean diastolic blood pressure, total 
cholesterol, LDL, HDL and triglyceride levels. Univariate and multivariate analyses were 
performed to determine the association between the main independent variable, 
awareness of one’s diabetes risk, and the dependent variable, adoption of diabetes risk 
reduction behavior, controlling for other risk factors. A p-value of <0.05 and 95% 
confidence intervals were used to determine statistical significance throughout all 
analyses performed. 
	  Results: After controlling for age, gender, race, education, annual family income, BMI, 
hypertension, mean systolic blood pressure, mean diastolic blood pressure, total 
cholesterol, LDL, HDL, and triglycerides, results from the multivariate analysis showed 
that subjects who were aware of their diabetes risk were more likely to adopt diabetes 
risk reduction behavior (OR= 1,734, 95 % CI=1.217-2.470). Females and non-Hispanic 
blacks, who were aware of their diabetes risk, were also more likely to adopt diabetes risk 
reduction behavior compared to males, non-Hispanic whites and Mexican Americans.  
An increase in the levels of education, annual family income and BMI was also 
associated with the adoption of diabetes risk reduction behavior. Stratification according 
to gender and ethnicity, showed that Mexican American males and females were more 
likely to engage in diabetes risk reduction behavior compared to non-Hispanic whites and 
non-Hispanic blacks (Mexican American males: OR: 2.496, CI: 0.792-7.868; Mexican 
American females: OR: 2.830, CI: 0.917-8.736). 
 
Conclusion: This study provides useful insights for health care providers and public 
health professionals who are developing health promotion and prevention interventions to 
address pre diabetes before it develops into type 2 diabetes. This study also allows the 
development of tailored interventions for specific genders and ethnic groups that are at 
risk. Results of this study indicate that Mexican Americans and females (in general) are 
more likely to adopt diabetes risk reduction behavior. Therefore, physicians and health 
care providers should develop culturally, linguistically and gender- specific education 
materials and programs for this particular gender and ethnic group. This in turn, may 
reduce the overall increasing prevalence of diabetes, reduce racial and gender disparities 
and may have a positive impact on the overall health of the U.S. population.
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CHAPTER I 
INTRODUCTION 
1a. Background 
 Diabetes mellitus is a metabolic disease condition characterized by 
hyperglycemia, or high blood glucose levels, which results from defects in insulin 
secretion, insulin action or both (Narayan, Zhang, Kanaya, Williams, Engelgau, 
Imperator &Ramachandran, 2006). Diabetes often goes undiagnosed because of its many 
symptoms that may seem to be harmless. For example, symptoms may include frequent 
urination, unusual thirst, extreme hunger, unusual weight loss, and extreme fatigue and 
irritability (ADA, 2011). Therefore, many people with diabetes do not seek treatment 
until symptoms worsen. Diabetes takes three major forms which include Type 1, Type 2 
and gestational diabetes. Type 1 diabetes usually occurs in children and adolescents and 
results from the destruction of the beta cells in the pancreas which leads to absolute 
insulin deficiency (Narayan et al., 2006). The body does not produce insulin in type 1 
diabetes and only 5% of people with diabetes have this form of disease (ADA, 2011). 
However, with the help of insulin therapy and other treatments people can learn to 
manage Type 1diabetes and live a healthy lifestyle. Type 2 diabetes, which accounts for 
approximately 85 to 95 percent of all diagnosed cases, is usually characterized by insulin 
resistance in which target tissues do not use insulin properly (Narayan et al., 2006). 
Millions of Americans have been diagnosed with Type 2 diabetes and many more are 
unaware they are at high risk (ADA, 2011). In addition, research has found that some 
groups of Americans have a higher risk for developing type 2 diabetes than others. For 
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example, Type 2 diabetes is more common in African Americans, Latinos, Native 
Americans, Asian Americans, Native Hawaiians and other Pacific Islanders (ADA, 
2011).A third type of diabetes, gestational diabetes, is first recognized during pregnancy, 
usually around the 24th week. (Narayan et al., 2006). 
In addition to the three forms of diabetes, is another condition known as 
prediabetes in which blood glucose levels are higher than normal but not yet high enough 
to be diagnosed as diabetes (ADA, 2011). Prediabetes is also a condition defined as  
having impaired fasting glucose (plasma glucose level of 100 to < 126 mg/dL after an 
overnight fast), impaired glucose tolerance (plasma glucose level of 140 to < 200 mg/dL 
after a 2-hour oral glucose tolerance test) or both (CDC, 2008). Three different tests such 
as the A1C, the fasting plasma glucose (FPG) and the Oral Glucose Tolerance Test 
(OGTT), are used by doctors to determine if one has prediabetes (ADA, 2011). The blood 
glucose levels measured after these tests determine whether one has normal metabolism, 
prediabetes or diabetes. There are approximately 79 million people in the United States 
that have prediabetes and recent research has shown some long-term damage to the body 
especially the heart and circulatory system (ADA, 2011). Persons with prediabetes are 
also at an increased risk for developing type 2 diabetes, heart disease, and stroke (CDC, 
2008). People that are diagnosed with prediabetes are aware of their high risk for 
developing diabetes. Therefore, they may engage in or adapt certain lifestyle changes that 
can prevent or delay development of diabetes and its complications (CDC, 2008). The 
benefits of engaging in risk reduction behaviors such as weight control, increased  
physical activity, and reduction in fat or caloric intake may outweigh the negative 
consequences associated with an increase in risk for diabetes. For example, the Diabetes 
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Prevention Program intervention trial showed that diet and exercise can lower the 
incidence of type 2 diabetes by 58% over 3 years among those at high risk for diabetes 
(CDC, 2008). Furthermore, clinical trials provide strong and consistent evidence that type 
2 diabetes can be prevented or delayed in high-risk adults with dysglycemia through 
structured lifestyle modifications, including dietary changes, moderate-intensity exercise, 
and modest weight loss (Geiss et al., 2010). However, the extent to which U.S. adults 
with prediabetes are making lifestyle changes consistent with reducing risk is unknown 
(Geiss et al., 2010). Additional research is also needed to determine the effect of lifestyle 
interventions on diabetes complications, particularly cardiovascular outcomes (Geiss et 
al., 2010). 
 Successful prevention trials, in combination with subsequent practical trials 
implemented in community settings, suggest that if people with dysglycemia can be 
efficiently identified and made aware of their risk status, they may be referred to effective 
community programs to change their levels of physical activity, dietary intake, and 
weight (Geiss et al., 2010). In addition, identification of high-risk states may also be 
useful to provide a stimulus for brief counseling by healthcare providers or for 
individuals to undertake self-directed behavior change (Geiss et al., 2010). Identification 
and awareness of prediabetes may be an important step in initiating effective lifestyle 
interventions (Geiss et al., 2010). Development of linguistically competent education 
materials for those people of different ethnicities and cultures and who are at a high risk 
for diabetes may encourage them to practice behaviors that may reduce or delay the onset 
of diabetes.  
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Furthermore, interventions to prevent or delay onset of type 2 diabetes in persons 
with prediabetes are feasible and cost effective. It is found that lifestyle interventions are 
more cost effective than medications (CDC, 2008). One study evaluated the cost 
effectiveness of a screening program for pre diabetes which was followed up by 
treatment with pharmaceutical interventions or lifestyle interventions (diet, exercise, or 
diet and exercise) in order to prevent or slow the onset of diabetes in those at high risk 
(Bertram, Lim, Barendregt&Vos, 2010). Results indicated that the most cost-effective 
intervention options were diet and exercise combined with pharmaceutical medication 
metformin (Bertram et al., 2010). 
The gap in prevalence between those with prediabetes and those aware of their 
condition presents an opportunity to reduce the burden of diabetes by increasing 
awareness of prediabetes and encouraging adoption of healthier lifestyles and risk 
reduction activities (CDC, 2008).  Implementation of intervention programs that are 
culturally and linguistically appropriate may lead high risk individuals to engage in 
lifestyle modifications such as diet, physical activity and weight control, which in turn 
may be economically and monetarily cost effective for the individual and the nation as a 
whole. 
1b. Purpose of Study 
 This study will examine U.S. males and females of different ethnicities (Non-
Hispanic Whites, Non-Hispanic Blacks and Mexican Americans). It will identify subjects 
that are aware of their health risk for diabetes and whether they will perform risk 
reduction behavior in present of other risk factors which include age, gender, ethnicity, 
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education, socioeconomic status (determined from annual family income), and biological 
factors such as body mass index (BMI), hypertension, total cholesterol, LDL, HDL, and 
triglyceride levels.  Although prediabetes is defined as having impaired fasting glucose or 
impaired glucose tolerance, but not (yet) having diabetes, this study will utilize diabetes-
related questions from the National Health and Nutrition Examination Survey 2007-2008, 
NHANES 2007-2008, to define those individuals aware of their high risk for diabetes. 
The NHANES 2007-2008 questions: Ever told you have prediabetes? and Ever told you 
have health risk for diabetes? were used to determine an individual’s awareness of their 
health risk for diabetes.  
 The identification of an individual’s awareness of their health risk for diabetes or 
prediabetes, may encourage them to adapt life style modifications and to seek 
interventions to reverse their risk for diabetes. Since this study focuses on U.S. adults of 
different ethnicities and genders it may encourage the development of future programs 
and interventions specifically tailored to target those populations who are at a higher risk 
for diabetes.  
1c. Research Questions 
Question #1:  Is the awareness of one’s diabetes risk associated with the involvement in 
diabetes risk reduction behavior including ongoing weight control, increase in physical 
activity and fat/calories reduction? 
Null Hypothesis # 1: Subjects who are aware of their diabetes risk would not be more 
likely to engage in diabetes risk reduction behavior compared to those who are unaware. 
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Alternate Hypothesis #1: Subjects who are aware of their diabetes risk would be more 
likely to engage in diabetes risk reduction behavior compared to those who are unaware. 
Question # 2: Will the relationship between one’s awareness of diabetes risk and 
participation in diabetes risk reduction behavior vary by race/ethnicity? 
Null Hypothesis #2: The relationship between one’s awareness of diabetes risk and 
participation in diabetes risk reduction behavior would not vary by race/ethnicity. 
Alternate Hypothesis # 2: The relationship between one’s awareness of diabetes risk and 
participation in diabetes risk reduction behavior would vary by race/ethnicity. 
Question # 3: Will the relationship between one’s awareness of diabetes risk and 
participation in diabetes risk reduction behavior vary by gender? 
Null Hypothesis # 3: The relationship between one’s awareness of diabetes risk and 
participation in diabetes risk reduction behavior would not vary by gender? 
Alternate Hypothesis # 3: The relationship between one’s awareness of diabetes risk and 
participation in diabetes risk reduction behavior would vary by gender?   
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CHAPTER II 
LITERATURE REVIEW 
The literature review examines the epidemiology of diabetes and prediabetes in 
the U.S and around the world and their associated risk factors. The following chapter 
presents scientific literature that supports the inclusion of the variables of interest in this 
study. Since there are very limited studies on prediabetes, risk factors for diabetes were 
examined as they are similar to the risk factors for prediabetes.  
2a. Epidemiology of Diabetes and Prediabetes 
 Type 2 diabetes mellitus is a major cause of morbidity and mortality in the United 
States and countries around the world and may contribute substantially to health care 
costs (Moore, Zgibar, &Dasanayake, 2003). Diabetes affects at least 5 percent of the U.S. 
population, while another 3 percent of the population may have the disorder but have not 
been diagnosed (Moore et al., 2003). Although the epidemic of diabetes in the United 
States has been observed over the past 2 decades, there is an expected continued rise in 
the incidence of diabetes as the population ages, a continued increase in adult obesity 
rates, and an increase in the population of minority groups that are at high risk for 
diabetes (Deshpande, Harris-Hayes &Schootman, 2008). In addition, rising childhood 
obesity rates and the increasing diagnosis of type 2 diabetes among children and 
adolescents have become an increasingly serious health crisis, which will result in more 
people having and managing diabetes for most of their lives (Deshpande et al., 2008). In 
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2005, it was estimated that more than 20 million people in the United States had diabetes 
(Deshpande et al., 2008). Approximately 30% of these people had undiagnosed cases 
(Deshpande et al., 2008). In addition, an estimated 1.5 million new cases of diabetes were 
diagnosed. (Deshpande et al., 2008). The incidence and prevalence of diabetes mellitus 
are increasing with more than 135 million people affected worldwide (Moore et al., 
2003). Although the incidence describes increases in the number of people affected by 
the disease, the prevalence describes the overall burden of the disease in the population 
(Deshpande et al., 2008). The National Health and Nutrition Examination Survey, 
NHANES, provides estimates for both diagnosed and undiagnosed diabetes (Deshpande 
et al., 2008). Based on prevalence estimates from NHANES for 2005, the total 
prevalence of diabetes (both diagnosed and undiagnosed) was estimated at 20.8 million 
or 7.0% of the U.S. population (Deshpande et al., 2008). Of these, 14.6 million were 
diagnosed and 6.2 million almost 30% of all diabetes cases were undiagnosed 
(Deshpande et al., 2008). In the United States, the prevalence and incidence of diabetes 
have increased dramatically during the past 2 decades (Deshpande et al., 2008). 
According to data from the National Health Interview Survey, NHIS, for the period from 
1980 to 2005, the age-adjusted prevalence of diagnosed diabetes was fairly stable at 
about 3.0% from 1980 to 1990 and then begun to increase (Deshpande et al., 2008). In 
1990, the age-adjusted prevalence rate was 2.9% (Deshpande et al., 2008). It increased to 
4.5% in 2000 and to 5.3% in 2005 (Deshpande et al., 2008). The overall prevalence of 
diagnosed diabetes increases with age and the rate of increase overtime has been longest 
in people over 65 years of age (Deshpande et al., 2008). The prevalence of self-reported 
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diagnosed diabetes has increased over time from 1997 to 2005 in all age groups 
(Deshpande et al., 2008). 
Prediabetes is a precursor condition to diabetes where people can have impaired 
fasting glucose (IFG)  or impaired glucose tolerance (IGT) or both.From 1988 to 1994, 
approximately 25% of a cross-sectional sample of U.S. adults 40 to 74 years of age were 
classified as having prediabetes (Deshpande et al., 2008). For the year 2000, this would 
mean that 12 million people in the United States had prediabetes (Deshpande et al., 
2008). In 2005 to 2008, based on fasting glucose or A1c levels, 35% of U.S adults aged 
20 years or older had prediabetes (50% of those aged 65 years or older) (CDC, 2011). 
Applying this percentage to the entire U.S. population in 2010 yields an estimated 79 
million Americans, aged 20 years or older, with prediabetes (CDC, 2011). On the basis of 
fasting glucose or A1c levels, and after adjusting for population age differences, the 
percentage of U.S. adults aged 20 years or older with prediabetes in 2005 to 2008 was 
similar for non-Hispanic whites (35%), non-Hispanic blacks (35%), and Mexican 
Americans (36%) (CDC, 2011).According to the IDF Diabetes Atlas, currently, the 
number of cases of impaired glucose tolerance (2010) worldwide is estimated to be 
approximately 340 million (Rhee & Woo, 2011). North America has the highest 
prevalence of impaired glucose tolerance in the world, with 10.4% (Rhee et al., 2011). 
For Europe and the Middle East, the values are 8.9% and 8.2% respectively (Rhee et al., 
2011). There is also a predicted increase in the prevalence of pre diabetes world wide. It 
is found that by 2030, the global prevalence of impaired glucose tolerance is estimated to 
reach 8.4%, which will be approximately 456 million people (Rhee et al., 2011). 
2b. Risk Factors for Prediabetes and Diabetes 
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The biology and pathogenesis of diabetes is complex and a number of modifiable 
and nonmodifiable risk factors increase the risk for diabetes. Risk factors for type 1 
diabetes include family history, race and certain viral infections during childhood 
(Deshpande et al., 2008). Risk factors for type 2 diabetes are more diverse where some 
are modifiable and others are not. Nonmodifiable risk factors for type 2 diabetes include 
age, gender, ethnicity, family history, history of gestational diabetes and low birth weight 
(Deshpande et al., 2008). Modifiable or lifestyle risk factors include BMI, physical 
inactivity, poor nutrition, hypertension, smoking, alcohol use, education, total cholesterol, 
LDL, HDL, and triglyceride levels (Deshpande et al., 2008). This study examines the 
following risk factors: age, gender, education, annual family income, BMI, hypertension, 
mean systolic blood pressure, mean diastolic blood pressure, total cholesterol, LDL, 
HDL, and triglycerides. 
a. Age 
The age of an individual is one risk factor for pre diabetes and type 2 diabetes. It 
is found that diabetes incidence and prevalence increases with age (Deshpande et al., 
2008). In 2005, the Centers for Disease Control reported that the prevalence of diabetes 
among people aged 20 years or older was 20.6 million (9.6% of the people in that age 
group), and the prevalence of diabetes increased with age (10.3 million people aged 60 
years or older, or 20.9% of those in that age group, had diabetes.) (Deshpande et al., 
2008). Rhee et al. also found that even in NHANES subjects, the prevalence of IFG and 
IGT increase proportionally with age (2011). In a study by Cowie et al. the prevalence of 
IFG, IGT and total pre diabetes, crude prevalence of either IFG or IGT, according to age 
was observed (2009). The results of the study indicated that in individuals over the age of 
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20 years, 25.7% had IFG (Cowie et al., 2009). IFG also increased with age, doubling 
between ages 20-39 and 40-59 years (Cowie et al., 2009). For individuals over the age of 
60 years, the IFG levels remained constant (Cowie et al., 2009). IGT was found in 13.8% 
of those aged over 20 years which was about half the prevalence of IFG (Cowie et al., 
2009). The prevalence steadily increased with age, peaking at 35.1% in those aged 75 
years and above (Cowie et al., 2009). The total pre diabetes which is estimated by either 
IFG or IGT was about 30% among people 20 years and above (Cowie et al., 2009). The 
prevalence also increased with age, peaking at 75 years and above (Cowie et al., 2009). 
In another study by Harris et al. the prevalence of impaired fasting glucose increased 
from ages 20 to 39 years to age 60 to 74 years or ages above 75 years (1998). 
b. Ethnicity 
 The United States consists of a vast number of ethnic minorities and other 
population sub groups. Based on the 2000 Census data, ethnic minorities constitute 
approximately 25% of the overall population of the U.S (Dagogo-Jack, 2003). In 
addition, the population of minority groups has been increasing at a faster rate than the 
general U.S. population (Dagogo-Jack, 2003). Although the growth of these minority 
populations is a sign of diversity, minority ethnic groups suffer disproportionately from 
type 2 diabetes, pre diabetes and their long-term complications. There is no finding as to 
why ethnic disparities exist in the occurrence of diabetes however, genetic, 
environmental and lifestyle factors may likely account for the increased prevalence of 
type 2 diabetes among ethnic minorities (Dagogo-Jack, 2003). Furthermore, the increase 
in morbidity and mortality from diabetes may be the result of socioeconomic factors 
(Dagogo-Jack, 2003).  
12	  
	  
	  
Diabetes-related mortality is higher for minorities than for white persons, and the 
rate is increasing (Carter et al., 1996). It is found that African Americans and other ethnic 
minority groups suffer disproportionately from type 2 diabetes and its complications than 
do white Americans (Deshpande et al. 2008). Age-adjusted prevalence rates for 
diagnosed diabetes have been higher among African Americans and Hispanics compared 
with whites (Deshpande et al., 2008). African American women have the highest 
prevalence of diabetes compared with other racial or ethnic and gender groups 
(Deshpande et al., 2008). In 2005, the age-adjusted prevalence rate for diagnosed diabetes 
was 8.3% in African American women compared with 8 % in African American men, 
7.5% in Hispanic women, 7.1% in Hispanic men, 4.7% in white women and 5.4% in 
white men (Deshpande et al., 2008). Estimates show that 3.2 million African Americans 
currently have diabetes and the number of African Americans with diabetes is projected 
to triple by the year 2050, while the number of whites with diabetes is estimated to only 
double (Deshpande et al. 2008).  
The American Diabetes Association (ADA) states that type 2 diabetes is more 
common in African Americans, Latinos, Native Americans, Asian Americans, Native 
Hawaiians and other Pacific Islanders (ADA, 2011). In addition, after adjusting for 
population age differences, 2007-2009 national survey data for people diagnosed with 
diabetes found the following prevalence by race ethnicity for those 20 years or older: 
7.1% of non-Hispanic whites, 8.4% of Asian Americans, 12.6% of non-Hispanic blacks 
and 11.8% of Hispanics (ADA, 2011). Among Hispanics the rates were: 7.6% for 
Cubans, 13.3% for Mexican Americans and 13.8% for Puerto Ricans (ADA, 2011). 
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The 1976-1980 National Health and Nutrition Examination Survey (NHANES II) found 
the total prevalence of diabetes in blacks persons (diagnosed and undiagnosed) to be 1.5 
times greater than that of white persons (Carter et al., 1996). The NHIS also confirms this 
increased risk for black persons even after controlling for an increased prevalence of 
obesity (Carter et al., 1996). All Hispanic population subgroups studied to date have a 
greater prevalence of diabetes than do white persons (Carter et al., 1996). For example, 
data from the 1982-1984 Hispanic Health and Nutrition Examination Survey (HHANES) 
show that, among Hispanic persons living in the United States, the prevalence of non-
insulin dependent diabetes is greatest for Puerto Ricans and Hispanic persons living in 
the southwest while it is lowest for Cubans (Carter et al., 1996). The excess of diabetes in 
the Mexican-American population persists even when the greater overall and centralized 
obesity rates of the Mexican American population are compared with those of white 
persons (Carter et al., 1996). 
According to the 1990 census, Native Americans comprise more than 500 tribal 
organizations and about 1.9 million persons identified themselves as an American Indian 
or Alaska native (Carter et al., 1996). High prevalences of diabetes among most Native 
American tribes have been reported (Carter et al., 1996). For example, the Pima tribe in 
Arizona has one of the highest rates of diabetes in the world (Carter et al., 1996). 
The Seattle Japanese-American Community Diabetes Study also found that Asian 
Americans and Pacific Islander Americans had a higher prevalence of diabetes than that 
reported for the U.S. white population (Carter et al., 1996). Carter et al. reported that 
Filipinos had the highest prevalence of diabetes among the four largest ethnic Asian 
groups in Hawaii (Chinese, Filipino, Japanese, and Korean) (1996). In addition, all 
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groups had higher prevalences than those of white persons (Carter et al., 1996). Few 
incidence studies on diabetes have been done thus far however, incidence rates in the 
United States have been found to be higher in black persons, Mexican Americans, the 
Pima tribe and Japanese Americans compared to white individuals (Carter et al., 1996). 
c. Gender 
 The prevalence of prediabetes and diabetes according to gender has been 
contradictory. Some studies have found that women suffer more disproportionately from 
diabetes while others have found men to have a slightly higher prevalence. For example, 
Moore et al. (2003) stated that the prevalence of diabetes in adults is slightly higher in 
women and increases significantly with age. Another study which used the 2002 and 
2004 core interviews of the U.S. nationally representative Health Retirement Study 
(HRS) and the 2003 HRS diabetes-specific mail survey had found that women had 
significantly higher HbA1c levels, blood pressure, body mass index and more frequent 
occurrence of early complications than men (Chiu & Wray, 2011). In addition, this study 
also found that women reported significantly less frequent exercise behavior and had 
lower scores than did men on diabetes coping status, perceived control, self efficacy, and 
perceived family support, but higher scores on depressive symptoms, compared to men 
(Chiu & Wray, 2011).  
In contrast, results from a Canadian study, that used the 1996 to 1997 National 
Population Health Survey, indicated that males in almost all age groups, had a higher 
prevalence of diabetes than females (Choi & Shi, 2001). The only exception was in the 
35 to 44 age group, in which males had a slightly lower prevalence (1.1%) than females 
15	  
	  
	  
(1.5%) (Choi et al., 2001). The overall odds ratio for diabetes was 1.44 comparing males 
with females, after adjusting for a number of potential confounders (Choi et al., 2001). In 
regards to gender, while this study found a higher proportion of males (54% males, 46% 
females) among Canadian patients with diabetes, studies in the United States found a 
higher proportion of females (42% males, 58% females) with diabetes (Choi et al., 2001).  
Another study evaluated the prevalence and time trends for diagnosed and 
undiagnosed diabetes, impaired fasting glucose and impaired glucose tolerance in U.S. 
adults based on the Third National Health and Nutrition Examination Survey, 1988-1994 
(NHANES III) (Harris, Flegal, Cowie, Eberhardt, Goldstein, Little, Wiedmeyer & Byrd-
Holt, 1998).  It was found that for the total prevalence of diabetes, prevalence was similar 
for men and women in each age group (Harris et al., 1998). However, the prevalence of 
impaired fasting glucose was higher for men than for women in each racial or ethnic 
group, and the age standardized rate in men versus women was 1.8 for all races combined 
(Harris et al., 1998). Lastly, the total prevalence of diabetes and impaired fasting glucose 
combined was estimated to be 15.6 million for men and only 13.4 million for women 
(Harris et al., 1998).  
d. Education as Socioeconomic Status 
 The prevalence of type 2 diabetes varies with socioeconomic status (SES) within  
different populations. SES is a complex construct and most often different variables such 
as education, income, and occupation, that are used to measure it, can reflect different 
specific exposures (Robbins, Vaccarino, Zhang & Kasl, 2001). Many studies have found 
an inverse relationship between education and diabetes prevalence. For example, in the 
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United States, intragroup comparisons among white persons, black persons, Hispanic 
persons, and Japanese Americans show an association between lower socioeconomic 
status or education level and higher prevalence of diabetes (Carter et al., 1996). This 
finding is due to the fact that large proportions of black and Hispanic populations live in 
poverty and have less than a high school education (Carter et al., 1996). Therefore, 
socioeconomic status may strongly influence the prevalence of diabetes in these minority 
groups (Carter et al., 1996). 
 Robbins and colleagues examined the association of diabetes with different 
measures of SES, education as one of them, within each of 4 strata-African American 
women, non-Hispanic White women, African American men and non-Hispanic white 
men (2001). The study found that education was a significant predictor of diabetes 
prevalence among African American women and that education was also inversely 
associated with diabetes prevalence among non-Hispanic white women in particular for 
the group with more than 12 years of education (Robbins et al., 2001). However, 
education had a weak inverse gradient with diabetes prevalence among non-Hispanic 
white men with an odds ratio for those with more than 12 years of education of 0.60 
relative to those with less than 9 years of education (Robbins et al., 2001). Similarly, 
education did not yield significant associations with diabetes in African American men 
(Robbins et al., 2001). The analyses from this study provide strong, consistent evidence 
that SES, measured by education, income and occupation, is inversely associated with 
type 2 diabetes in both African American and non-Hispanic white women (Robbins et al., 
2001). However, they do not provide such evidence for African American or non-
Hispanic white men (Robbins et al., 2001). 
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 Another study determined and quantified socioeconomic position (SEP), a 
similar measure to SES, inequalities in diabetes in different areas of Europe for men and 
women. Similar to the previous mentioned study, it was found that low SEP was related 
to a higher prevalence of diabetes (Espelt, Borrell, Roskam, Rodriguez-Sanz, Stirbu, 
Dalmau-Bueno, Regidor, Bopp, Martikainen, Leinsalu, Artnik, Rychtarikova, Kalediene, 
Dzurova, Mackenbach & Kunst, 2008).   For example, men who attained a level of 
education equivalent to lower secondary school or less had a prevalence ratio of 1.6 
compared with those who attained tertiary level education, whereas the corresponding 
value in women was 2.2 (Espelt et al., 2008). In addition, one study found that people 
with less than primary education have 2.69 higher risk of having diabetes than those with 
primary education or more (Espelt, Goda, Franch&Borrell, 2011). 
Furthermore, there is an inverse relationship between SEP, morbidity and 
mortality. For example, Saydah and collegues examined disparities in diabetes-related 
mortality for socioeconomic status groups in nationally representative U.S. samples 
(2010). Results indicated that having less than a high school education was associated 
with a twofold higher mortality from diabetes after controlling for age, gender, 
race/ethnicity, marital status, and body mass index compared with adults with a college 
degree or higher education level (Saydah & Lochner, 2010). In addition, the risk of 
diabetes-related death demonstrated a clear gradient from lowest to highest education 
level (Saydah et al., 2010). A study by Sims et al. found that the lack of awareness of 
diabetes was associated with low education and low occupation in women but not in men 
and that the lack of treatment was also associated with low education in women (2011).  
e. Income as SES 
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 Income is another measure that researchers use to measure SES and its constituent 
elements which are accepted as being determinants of health. Income is not only a direct 
measure of economic resources but also a primary determinant of social prestige and 
status in the United States. There is considerable evidence to show that low income is 
associated with shorter life expectancies and increased mortality (Rabi et al., 2006). 
Research has also found that diabetes may be up to two times more prevalent in low 
income populations compared to wealthy populations (Rabi et al., 2006). One study 
examined the socioeconomic gradient in diabetes prevalence, awareness, treatment, and 
control among African Americans and found that in adjusted models, low-income men 
and women had greater probabilities of diabetes than high income men and women 
(Sims, Diez Roux, Boykin, Sarpong, Gebreab, Wyatt, Hickson, Payton, Ekunwe & 
Taylor, 2011). Associations of low income with diabetes prevalence persisted and 
remained statistically significant after risk factor adjustment in both men and women 
(Sims et al., 2011). In addition, women had a higher prevalence of diabetes than men 
(19.6% vs. 15.9%), but greater awareness (90% vs. 88.2%), treatment (86.8% vs. 84.4%), 
and control (39.2% vs. 35.8%) (Sims et al., 2011). 
Another study that examined socioeconomic status and diagnosed diabetes 
incidence, found that among women, diabetes incidence was inversely associated with 
income (Robbins, Vaccarino, Zhang & Kasl, 2005).  Among men, a trend toward lower 
diabetes incidence with higher income and higher education was evident (Robbins et al., 
2005). This inverse association between income and diabetes risk is complex. However, 
it has been speculated that the increased diabetes risk seen in low income groups is 
related to the increased prevalence of obesity within this group (Rabi et al., 2006). 
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 A Canadian study by Rabi et al. was conducted to determine whether income is 
associated with referral to a diabetes center within a universal health care system (2006). 
Results indicated that low income is associated with a higher prevalence of diabetes and a 
higher population rate of referral (Rabi et al., 2006) In regard to access to diabetes care, it 
is found that individuals from lower socio-economic groups have impaired access to care 
reflected in longer wait times and fewer referrals for specialist care (Rabi et al., 2006). 
This contributes to the observation of worse health outcomes such as the increased rate of 
acute diabetic complications. The impaired access to care may also affect one’s 
engagement in diabetes risk reduction behaviors.  Rabi et al. suggest that neighborhood 
and community level factors contribute to the increased diabetes risk seen in low income 
populations (2006). For example, the “built” environment has been shown to be a clear 
barrier to physical activity in poorer neighborhoods (Rabi et al., 2006). In addition, low 
income communities have been shown to have less biomass and park-space compared to 
wealthier communities (Rabi et al., 2006). There may also be a perception that it is less 
safe to walk in a poorer neighborhood which deters not only physical activity but erodes 
the sense of community among residents (Rabi et al., 2006). Robbins and colleagues 
suggest that while most clinicians who treat patients with diabetes in the United States are 
aware that type 2 diabetes occurs more frequently among racial and ethnic minorities, 
many are not aware that it is also more likely to appear among patients with low SES, 
regardless of race or ethnicity (2005). Findings of this study state that effective, 
population-based interventions to decrease obesity and improve health behaviors may 
reduce, but not eliminate, SES disparities in diabetes incidence (Robbins et al., 2005). 
f. Body Mass Index, BMI 
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 Obesity is defined medically as a state of increased adipose tissue of sufficient 
magnitude that may result in adverse health consequences. (Gómez-Ambrosi, Silva, 
Galofré, Escalada, Santos, Gil, Valentí, Rotellar, Ramírez, Salvador &Frühbeck, 2011). 
Therefore, obesity is a major modifiable risk factor for type 2 diabetes and many other 
diseases (Choi et al., 2001). BMI has been traditionally used as a surrogate measure of 
adiposity and is the most frequently used diagnostic tool in the current classification 
system for obesity (Gómez-Ambrosi et al., 2011). Many studies have shown consistent 
results that the prevalence of diabetes increases with obesity (BMI) in both males and 
females. Choi et al. found a differential effect of obesity on the prevalence of diabetes in 
males and females (2001). For males, the prevalence of diabetes started to increase when 
BMI reached 27 (overweight category) but for females the prevalence of diabetes started 
to increase at a lower BMI level of 25 (Choi et al., 2001). This is consistent with other 
studies, which have shown that the per unit increase in BMI had a larger effect on the risk 
of diabetes among women than men. However, results of this study also indicate the need 
to use different criteria to define obesity for women and men. Men on average have a 
larger body build than women and therefore obesity should be defined differently based 
on BMI (Choe et al., 2001). 
 Another study determined whether the associations of BMI and fat distribution 
with diabetes risk are modified by race. Previous research on the prevalence and 
incidence of type 2 diabetes in the U.S. has consistently shown the frequency of diabetes 
to be higher among black than among white Americans and to be higher among obese 
individuals and those with centralized fat distribution (Resnick, Valsania, Halter & Lin, 
1998). Research has also found higher BMI and subscapular-to-triceps skinfold ratio 
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(STR) among blacks and showed that blacks were at a substantially higher 16-year risk of 
developing diabetes than whites (Resnicketal., 1998). Resnick et al. discovered that the 
age-adjusted cumulative incidence of diabetes was greater with increasing BMI  in all 
race-sex groups (1998). For example, blacks were at higher risk of diabetes at all levels 
of BMI compared with whites. However, at lower BMI, the relative risk of diabetes for 
black: white subjects was much larger than at higher levels of BMI (Resnick et al., 1998).  
Studies have also focused on modifying an individual’s BMI and weight to 
prevent and reduce the risk for diabetes. For example, a study by the Diabetes Prevention 
Program identified individuals who were at risk for developing diabetes due to elevated 
fasting plasma glucose or impaired glucose tolerance levels that were not yet in the 
diagnostic range, in order to determine if the medication metformin or an intensive 
lifestyle intervention, which consists of a goal of 7% weight loss and 150 min/wk of 
moderate physical activity, could delay or prevent the onset of diabetes (Crandall, 
Knowler, Kahn, Marrero, Bray, Haffner, Hoskin& Nathan, 2008). Results indicated that 
fifty percent of the lifestyle-intervention group lost 7% of their body weight and that the 
3-year incidence of diabetes in the metformin group was 31% lower than that in the 
placebo group (Crandall et al., 2008). In addition, the incidence of diabetes was 58% 
lower in the lifestyle group than in the placebo group (Crandall et al., 2008). Weight loss 
was the predominant predictor of reduced diabetes incidence, with a 16% reduction in 
risk per kilogram of weight lost (Crandall et al., 2008). The effectiveness of the Diabetes 
Prevention Program lifestyle intervention was similar in all ethnic groups and both sexes 
and was greatest in older participants (Crandall et al., 2008). 
g. Blood Pressure and Hypertension 
22	  
	  
	  
 The incidence of type 2 diabetes is increasing rapidly and research has shown a 
close relationship between hypertension and type 2 diabetes. Despite this close 
relationship, little information exists on the relationship of blood pressure levels with the 
subsequent development of type 2 diabetes (Conen, Ridker, Mora, Buring & Glynn, 
2007). In addition, few studies have analyzed the precise relationship between blood 
pressure and incident type 2 diabetes. Gress et al. found that individuals with 
hypertension had a relative risk of 2.34 (95% confidence interval 2.16-2.73) of 
developing type 2 diabetes compared with individuals without hypertension (2000).  
However, no multivariable adjustment of this association was performed in their study 
(Conen et al., 2007). Recently, hypertension has further emerged as a potential risk factor 
based on several longitudinal studies’ findings that higher blood pressure is associated 
with increased risk of diabetes (Wei, Coady, Goff, Brancati, Levy, Selvin, Vasan& Fox, 
2011). However, it still remains unclear whether hypertension is associated with diabetes 
above and beyond other known risk factors such as age, race, and adiposity (Wei et al., 
2011). 
 Wei et al. examined the association between high blood pressure and incident 
type 2 diabetes in African Americans and whites aged 35 to 54 years at baseline (2011). 
Results indicated that 14.6% of African Americans and 7.9% of whites developed 
diabetes and that the age-adjusted incidence was increasingly higher across increasing 
blood pressure groups, with the incidence lowest in the normal blood pressure group and 
highest in the hypertension group (Wei et al., 2011). In addition, after adjustment for age, 
sex, BMI, fasting glucose, HDL cholesterol and triglycerides, prehypertension or 
hypertension (compared with normal blood pressure) was associated with greater risks of 
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diabetes in whites, but not African Americans (Wei et al., 2011). Hazard ratios for 
developing diabetes among normotensive, prehypertensive, and hypertensive African 
Americans versus normotensive whites were 2.75, 2.28, and 2.36 respectively (Wei et al., 
2011). Wei et al. also suggested that in African Americans the higher incidence of 
diabetes among hypertensive individuals may be explained by concomitantly greater 
adiposity and other cardiometabolic risk factors (2011). In whites, the association of both 
prehypertension and hypertension with incident diabetes is partially explained by these 
and other risk factors. However, regardless of baseline blood pressure status, research has 
found that African Americans have a greater risk of developing diabetes than whites (Wei 
et al., 2011). 
Furthermore, Conen et al. conducted a prospective cohort study and examined the 
relationship of blood pressure and blood pressure progression with the subsequent 
development of type 2 diabetes in women (2007). Results showed that the baseline blood 
pressure and blood pressure progression are strong and independent predictors of incident 
type 2 diabetes among initially healthy women (Conen et al., 2007). During the median 
follow-up of 10.2 years, 1672 out of 38172 women developed type 2 diabetes (Conen et 
al., 2007). After 10 years of follow up, 1.4, 2.9, 5.7, and 9.4% of women across the four 
baseline blood pressure categories developed type 2 diabetes (Conen et al., 2007). In 
addition, women with baseline hypertension had a seven-fold increased risk of 
developing diabetes compared with women with optimal blood pressure (Conen et al., 
2007). Even after multivariable adjustment, these risk factors were attenuated but 
remained statistically significant (Conen et al., 2007). Thus, there was still a three-fold 
increased risk for type 2 diabetes among women with hypertension compared with 
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women with optimal blood pressure (Conen et al., 2007). Lastly, women progressing to 
hypertension had a 64% increased risk of incident diabetes, and this risk more than 
doubled in those with baseline hypertension (Conen et al., 2007). 
h. Cholesterol, HDL and LDL 
Persons with type 2 diabetes feature important modification of both low density 
lipoprotein, LDL, and high density lipoprotein particles (Krauss, 2004). Insulin resistance 
and type 2 diabetes are associated with a clustering of interrelated plasma lipid and 
lipoprotein abnormalities, which include reduced HDL cholesterol, a predominance of 
small dense LDL particles, and elevated triglyceride levels (Krauss, 2004). It is found 
that these abnormalities occur in many patients despite normal LDL cholesterol levels 
(Krauss, 2004). Lipid modification is also a feature of the insulin resistance syndrome, 
which underlies many cases of type 2 diabetes (Krauss, 2004). In fact, pre-diabetic 
individuals often exhibit an atherogenic pattern of risk factors that includes higher levels 
of total cholesterol, LDL cholesterol, and triglycerides and lower levels of HDL 
cholesterol than non diabetic individuals (Krauss, 2004). Although the plasma LDL 
cholesterol level is usually normal in type 2 diabetic patients, metabolism of LDL is 
significantly modified (Krauss, 2004). The increased production of precursors of small 
dense LDL particles results from the increased hepatic production and/or retarded 
clearance from plasma of large VLDL (Krauss, 2004). Plasma VLDL levels correlate 
with increased density and decreased size of LDL which in turn is inversely related to 
plasma levels of HDL (Krauss, 2004). It is found that small dense LDL particles appear 
to arise from the intravascular processing of specific larger VLDL precursors through a 
series of steps, including lipolysis (Krauss, 2004). Further triglyceride enrichment of the 
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lipolytic products through the action of cholesteryl ester transfer protein, together with 
hydrolysis of triglyceride and phospholipids by hepatic lipase, leads to increased 
production of small dense LDL particles (Krauss, 2004). The reductions in HDL 
associated with type 2 diabetes and insulin resistance are multifactorial, but a major 
factor appears to be increased transfer of cholesterol from HDL to triglyceride-rich 
lipoproteins, with reciprocal transfer of triglyceride to HDL (Krauss, 2004). Triglyceride-
rich HDL particles are hydrolyzed by hepatic lipase and, as a result are rapidly 
catabolized and cleared from plasma (Krauss, 2004). The combination of increased 
production and decreased catabolism of triglyceride-rich lipoproteins accentuates 
hypertriglyceridemia (Kreisberg, 1998). Hypertriglyceridemia changes the composition 
of all lipoproteins, enriches them with triglycerides, and makes them better substrates for 
hepatic lipase, which leads to decreased levels of HDL cholesterol and increased 
production of LDL cholesterol (Kreisberg, 1998). Therefore, as triglycerides increase 
within the “normal range”, abnormalities in HDL and LDL become more apparent. 
Krauss also found that behavioral interventions such as diet and exercise can improve 
diabetic dyslipidemia however, for most patients, pharmacological therapy is needed to 
reach treatment goals (2004). In addition, there are several classes of medications that can 
be used to treat lipid and lipoprotein abnormalities associated with insulin resistance and 
type 2 diabetes. Epidemiologic and intervention studies have shown significant 
improvement in the features of diabetic dyslipidemia with medical nutrition therapy and 
physical activity (Krauss, 2004). 
i. Triglycerides 
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Lipid abnormalities in patients with type 2 diabetes are likely to play an important 
role in the development atherogenesis. These lipid disorders include not only quantitative 
but also qualitative abnormalities of lipoproteins (Vergés, 2005). It is found that plasma 
triglyceride level is frequently increased in type 2 diabetes which is due to an augmented 
number of VLDL and IDL particles (Vergés, 2005). In addition, research has shown that 
reducing excess triglycerides in the blood can lower you chance of developing diabetes as 
well as heart disease and other problems (MSN, 2011). In a 10 year study of otherwise 
healthy men, researchers found that those with the lowest triglyceride levels were least 
likely to develop diabetes (MSN, 2011). In addition, men with high triglycerides who 
lowered them with healthy lifestyle changes had a diabetes risk that was similar to those 
who never had a triglyceride problem at all. The results of this study were true even when 
controlling for diabetes risk factors such as blood pressure, physical activity, body mass 
index, family history and more (MSN, 2011). Lastly, researchers don’t fully understand 
the relationship between triglycerides and diabetes. However, they believe that excess 
triglycerides can increase insulin resistance in some people (MSN, 2011). 
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CHAPTER III 
METHODOLOGY 
3a. Data Source and Study Population 
 The data for this study came from the 2007-2008 National Health and Nutrition 
Examination Survey, 2007-2008 NHANES.  This data source is provided by the National 
Center for Health Statistics, NCHS, and is an annual representative survey of the U.S. 
civilian non-institutionalized population. The NHANES program began in the early 
1960s and since then has been conducted as a series of surveys focusing on different 
population groups or health topics (CDC, 2009). NHANES assesses the health and 
nutritional status of adults and children in the U.S. (CDC, 2009). This survey is unique in 
that it combines interviews and physical examinations. Survey participants are 
interviewed at home and are invited to a mobile examination center to undergo various 
examinations and laboratory measurements (Geiss et al., 2010). The survey examines a 
nationally representative sample of about 5,000 persons each year in which these persons 
are located in various counties across the country (CDC, 2009). The interview portion of 
this survey consists of demographic, socioeconomic, dietary, and health-related 
questions, while the examination component includes medical, dental, and physiological 
measurements (CDC, 2009). Furthermore, this is the only national survey that reports and 
captures information about diabetes and prediabetes from an interview as well as 
laboratory measurements such as FPG, IGT and glycalated hemoglobin level. An 
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informed consent is obtained from each participant for the interview as well as the 
laboratory examination (CDC, 2009). Findings from NHANES are used to determine the 
prevalence of major diseases, such as diabetes, and risk factors for these diseases. Risk 
factors, those aspects of a person’s lifestyle, constitution, heredity, or environment that 
may increase the chances of developing a certain disease or condition are also examined 
(CDC, 2009).  In addition, the survey sample is selected in order to represent the U.S. 
population of all ages. To produce reliable statistics, NHANES over-samples persons 60 
years in age and older, African Americans and Hispanics (CDC, 2009).  All participants 
of the survey visit the physician and have body measurements, laboratory examination, 
and dietary interviews. Since the U.S. population has been experiencing a dramatic 
growth in the number of older people, particular attention and extensive examination is 
performed for this population in question (CDC, 2009). NHANES information and data 
are made available to data users and researchers around the world through the internet 
and on easy-to-use CD-ROMs (CDC, 2009). Therefore, research organizations, 
universities, health care providers and educators benefit from using this data source. In 
addition, results from NHANES benefit people in the United States in important ways. 
For example, facts about the distribution of health problems and risk factors in the 
population provide researchers important clues to the causes of disease (CDC, 2009). 
For this study, data from the 2007-2008 NHANES diabetes questionnaire, 
laboratory, examination and demographic files were used. The demographic file provides 
family-level and individual-level information. All survey participants who have a 
household interview record have a demographics file record (CDC, 2009). The 
demographic file also includes the household interview and examination status codes, 
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interview and examination sample weights, languages of interview for the household and 
examination interviews, information about household reference person, proxy respondent 
codes and demographic variables about the survey participant (CDC, 2009). Persons 16 
years of age and older and emancipated minors were interviewed directly and a 
household interview was conducted in-person with an interviewer (CDC, 2009). In this 
study the following demographic variables were used: age, gender, ethnicity, education 
and annual family income. The examination variables included in this study were 
diastolic blood pressure, systolic blood pressure and body mass index. Laboratory 
variables that were used in this study included HDL, LDL, triglycerides and total 
cholesterol. The laboratory data also contains measures such as the OGTT and fasting 
blood glucose levels, FPG. This helped identifying those individuals that had 
undiagnosed diabetes. Standard diagnostic criteria were used to determine whether an 
individual had undiagnosed diabetes based on OGTT and FPG values. If an individual 
had an OGTT greater than 200 and FPG greater than 126 than the individual was 
excluded from the study. These laboratory values were the recommended values from the 
American Diabetes Association (2011). 
3b. Eligibility Criteria 
The diabetes questionnaire was used to determine those that are aware of their 
risk for diabetes (prediabetes), those that have diabetes and those individuals that are 
engaging in diabetes risk reduction behaviors. The questions asked to determine if an 
individual is at risk for diabetes was ever told you have prediabetes and ever told have 
health risk for diabetes. A new variable was than created called awareness of diabetes 
risk which included both of the questions ever told you have prediabetes or ever told 
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have health risk for diabetes and was the main independent variable in the study. Only 
those individuals aware of their risk for diabetes were included in this study. The 
question asked to determine if an individual has diabetes was doctor told has diabetes. If 
the individual was diagnosed with diabetes, than they were excluded from the study.  
Questions that determined if an individual was reducing their risk for diabetes were are 
you controlling weight, are you increasing physical activity, are you reducing fat/calories 
in diet, past year told control weight, past year told increase physical activity and past 
year told to reduce fat/calories in diet. A new variable called diabetes risk reduction 
behavior was than created from the ongoing risk behavior questions: are you controlling 
weight, are you increasing physical activity and are you reducing fat/calories in diet and 
was the main dependent variable of the study. The total sample before exclusions were 
made was 10149. However, after the exclusions according to the criteria mentioned, the 
total sample of NHANES respondents that met the study eligibility criteria was 4083.The 
4083 participants included in this study were also aged 20 years and above and were non-
Hispanic black, non-Hispanic white and Mexican American in ethnicity. In addition, 
males and females of the total sample were examined separately. It was found that 2007 
(49.2%) of the study respondents were males and 2076 (50.8%) were females. 
3c. Independent Variables 
The independent variables were obtained from the demographic, examination, 
laboratory and questionnaire files. These included age, ethnicity, education, annual 
family income, BMI, hypertension, mean systolic blood pressure, mean diastolic blood 
pressure, total cholesterol, LDL, HDL, and triglycerides.Any participant that did not have 
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complete information on the demographic, laboratory, examination and questionnaire 
component of the survey was eliminated from the study. 
Aware of Diabetes Risk: 
This variable was created from the questions: ever told you have prediabetes and 
ever told have health risk for diabetes. This was the main independent variable. 
Diabetes Risk Reduction Behavior: 
This variable was created from the ongoing diabetes risk reduction behavior questions 
which include: are you controlling weight, are you increasing physical activity and are 
you reducing fat/calories in diet. This was the dependent variable. 
Age: 
Age was reported as a whole number in years at time of screening. Only those 
individuals 20 years and above were included in this study.  
Gender: 
Gender of the participant was reported as either male or female and coded as 0 for 
male and 1 for female. 
Ethnicity: 
Ethnicity was categorized into three groups: non-Hispanic whites, non-Hispanic 
blacks and Mexican Americans.  
Education: 
32	  
	  
	  
 The education variable is the highest grade or level of education completed by 
adults 20 years and older (CDC, 2009). The response categories are: less than 9th grade 
education, 9-11th grade education (includes 12th grade and no diploma), High school 
graduate /GED, some college or associates (AA) degree, and college graduate or higher 
(CDC, 2009). Education level was self-reported and categorized into 3 groups: less than 
high school, high school, and college. 
Annual Family Income: 
This variable is the total family income variable and is released as an income 
range value. The income section of the household interview includes several questions 
about sources of income including wages, retirement income, disability payments, 
interest income, and assistance programs, but the amounts of income from each of the 
income sources were not obtained (CDC, 2009). The respondent was asked to report total 
family income for themselves and the other members of their family in dollars (CDC, 
2009). Annual Family income was categorized into three groups: less than $20,000, 
$20,000-$74,999 and $75,000 and above. 
BMI: 
Body mass index was reported as kg/m2. BMI was categorized into three groups: less 
than 25 as “normal”, 25 to 29.999 as “overweight” and greater than or equal to 30 as 
“obese”.  
Hypertension: 
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The hypertension variable was created from questions of the blood pressure 
questionnaire and mean systolic and diastolic blood pressure readings. Questions 
included: taking prescription for hypertension, told have prehypertension and borderline 
hypertension. If the survey participant also had a mean systolic blood pressure reading 
greater than 140 or a mean diastolic blood pressure reading greater than 90 than they 
were considered to have hypertension. Recommendations for the blood pressure readings 
came from the American Heart Association (2011). 
Mean Systolic Blood Pressure: 
 The systolic blood pressure readings came from the examination portion of the 
survey. The survey participant would rest quietly in a sitting position for 5 minutes 
determining the maximum inflation level (CDC, 2009). Three consecutive systolic blood 
pressure readings were taken to obtain an accurate blood pressure. Systolic blood 
pressure readings were reported in mm Hg. A mean systolic blood pressure reading was 
computed from the three readings. All blood pressure determinations were taken in the 
mobile examination center. 
Mean Diastolic Blood Pressure: 
 The diastolic blood pressure readings also came from the examination portion of 
the survey. The survey participant would rest quietly in a sitting position for 5 minutes 
determining the maximum inflation level (CDC, 2009). Three consecutive diastolic blood 
pressure readings were taken to obtain an accurate blood pressure. Diastolic blood 
pressure readings were reported in mm Hg.  A mean diastolic blood pressure reading was 
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computed from the three readings. All blood pressure determinations were taken in the 
mobile examination center. 
Total Cholesterol: 
 Total cholesterol was measured in serum using the Roche Modular P Chemistry 
analyzer (CDC, 2009).  In this enzymatic method, esterified cholesterol is converted to 
cholesterol by cholesterol esterase (CDC, 2009).  The resulting cholesterol is then acted 
upon by cholesterol oxidase to produce cholest-4-en-3-one and hydrogen peroxide (CDC, 
2009). The hydrogen peroxide then reacts with 4-aminophenazone in the presence of 
peroxidase to produce a colored product that is measured at 505 nm (secondary 
wavelength = 700 nm) (CDC, 2009). The final step is known as the Trinder reaction  
which is a single reagent, endpoint reaction that is specific for cholesterol. Total 
cholesterol was reported in mg/dL. 
LDL: 
 Serum LDL-cholesterol levels were derived on examinees that were examined in 
the morning session only. LDL is calculated from measured values of total cholesterol, 
triglycerides and HDL cholesterol according to the Friedewald calculation:  
[LDL-cholesterol] = [total cholesterol] – [HDL-cholesterol] – [triglycerides/5] where all 
values are expressed in mg/dL. 
HDL: 
For the HDL method, a magnesium/dextran sulfate solution is first added to the specimen 
to form water-soluble complexes with non-HDL cholesterol fractions. These complexes 
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are not reactive with the measuring reagents added in the second step. With addition of 
reagent 2, HDL-cholesterol esters are converted to HDL-cholesterol by PEG-cholesterol 
esterase. The HDL-cholesterol is acted upon by PEG-cholesterol oxidase, and the 
hydrogen peroxide produced from this reaction combines with 4-amino-antipyrine and 
HSDA under the action of peroxidase to form a purple/blue pigment that is measured 
photometrically at 600 nm (secondary wavelength = 700 nm). When the cholesterol 
measuring enzymes are modified with PEG, they are preferentially more reactive with 
HDL-cholesterol than the other cholesterol fractions. This is an endpoint reaction that is 
specific for HDL-cholesterol. HDL is reported in mg/dL. This method was from the 
Centers for Disease Control (2009).  
Triglycerides: 
 Triglycerides were measured in serum using Roche Modular P chemistry 
analyzer. In this enzymatic method reagent 1 (glycerol blanking) is added first. Free 
glycerol is converted to glycerol-3-phosphate (G3P) by glycerol kinase. G3P is acted 
upon by glycerol phosphate oxidase to produce dihydroxyacetone phosphate and 
hydrogen peroxide. The hydrogen peroxide combines with 4-chlorophenol under the 
action of peroxidase to produce an oxidation product that that does not react with the 
colorometric component of reagent 2. After this initial reaction sequence is completed, 
the Mod P records a blank absorbance reading. Then reagent 2 is added. The second 
reaction is driven by the reagents from bottle 1, with lipase added in reagent 2 to convert 
triglycerides to glycerol, and 4-aminophenzone added to react with the hydrogen 
peroxide produced in the last reaction. The reaction is measured at 505 nm (secondary 
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wavelength = 700 nm). This method is a two-reagent, endpoint reaction that is specific 
for triglycerides. This method was from the Centers for Disease Control (2009).  
3d. Statistical Analysis 
 The Statistical Package for the Social Sciences (SPSS) version 18 was used to 
organize and analyze the data in NHANES 2007-2008 and to make it suitable for the 
study.  To achieve sufficient subpopulation representation, NHANES oversampled 
certain populations (CDC, 2009). For example, NHANES oversampled all Hispanics, not 
just Mexican Americans (CDC, 2009). In addition, for each of the race/ethnicity domains 
the 12-15 and 16-19 year age domains were combined and the 40-59 year age minority 
domains were split into 10 year age domains 40-49 and 50-59. (CDC, 2009).This has led 
to an increase in the number of participants aged 40+ and a decrease in 12-19 year olds 
from previous cycles (CDC, 2009). Frequency tables were created using cross tabulation 
for males and females to determine the representation of categorical variables such as 
age, education, annual family income, BMI, and hypertension. Chi-square tests were 
conducted for the categorical variables for pairwise comparisons and to determine 
differences across groups. In addition, cross tabulation and pairwise comparisons were 
conducted for the ongoing and past year risk reduction behaviors for males and females. 
One way  ANOVA was conducted for the continuous variables which included age, mean 
systolic blood pressure, mean diastolic blood pressure, total cholesterol, LDL, HDL and 
triglycerides. Tukey post hoc tests were produced to determine differences across groups 
for the continuous variables. Males and females were examined separately for all the 
variables. Univariate and multiple logistic regression were performed for males and 
females separately to model diabetes risk reduction behavior among those participants 
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who were aware of their diabetes risk by age, education, annual family income, BMI, 
hypertension, mean systolic blood pressure, mean diastolic blood pressure, total 
cholesterol, LDL, HDL, and triglycerides. The odds ratio and the 95% confidence 
intervals were reported from the univariate and multivariate analysis to determine the 
strength and level of association between each of the independent variables and the main 
dependent variable. Throughout all analyses performed, a p-value of 0.05 and a 
confidence interval of 95% were used to determine statistical significance.  
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CHAPTER IV 
RESULTS 
4a. Sample Demographics 
The total sample of NHANES respondents that met the eligibility criteria was 
4083 out of which 2007 were males and 2076 were female participants. Males and 
females were examined separately. Percentages were reported for the categorical 
variables education, annual family income, BMI and hypertension while mean and 
standard deviations were presented for the continuous variables age, mean systolic blood 
pressure, mean diastolic blood pressure, total cholesterol, LDL, HDL and triglycerides. P-
values at the 95% confidence interval (P<0.05) are also presented for each listed 
continuous and categorical variable to determine statistical significance. 
  The demographic and biological characteristics of male and female participants 
are presented in table 1 and table 2 respectively. Over half of the male participants, 
56.5%, identified themselves as non-Hispanic whites, while non-Hispanic blacks and 
Mexican Americans each represented about a quarter of the sample, 23.0% and 20.6%. 
Females had a similar distribution in which 56% identified themselves as non-Hispanic 
whites and non-Hispanic blacks and Mexican Americans represented 23.4% and 20.6% 
of the total sample. For U.S male and female adults, mean age was statistically 
significantly higher for non-Hispanic whites compared to non-Hispanic blacks and 
Mexican Americans. Approximately 54% of Non-Hispanic white males and 55.1% of 
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non-Hispanic white females reported having a college level of education which was 
statistically significantly higher compared to non-Hispanic blacks and Mexican 
Americans. For annual family income, 78.9% of Non-Hispanic black males and 74.4% of 
non-Hispanic black females had more than $20,000. Mexican American males were more 
obese, 33.2%, which was statistically significantly higher than non-Hispanic white and 
non-Hispanic black males. In contrast, the proportion of non-Hispanic black females 
classified as obese according to BMI was significantly higher than the proportions for 
Mexican American and non-Hispanic white females. Non-Hispanic white males had the 
highest percentage for hypertension, 40.7% , which was statistically significantly higher 
than Mexican American and non-Hispanic black males. Non-Hispanic black females had 
the higher percentage for hypertension, 44.7%. The means of systolic blood pressure, 
diastolic blood pressure and HDL for non-Hispanic black males and females were 
statistically significantly higher than Mexican American and non-Hispanic white males 
and females. Mexican American males had the highest means for total cholesterol, LDL 
and triglycerides. However, LDL for Mexican American males was not statistically 
significantly higher than non-Hispanic white and black males.Non-Hispanic white 
females had the highest means for total cholesterol and LDL and were statistically 
significantly higher than Mexican American and non-Hispanic black females. Lastly, 
Mexican American females had the highest mean for triglyceride levels, 131.   
4b.Diabetes Risk Reduction Behavior Characteristics 
 Diabetes risk reduction behavior characteristics for U.S. adult males and females 
are shown in table 3 and 4.  Diabetes risk reduction variables include ongoing lifestyle 
changes such as controlling weight, physical activity and reduction of fat or calories in 
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diet, past year lifestyle changes, and diabetes risk reduction behavior which is a 
combination of the ongoing lifestyle changes. Percentages (%) and the count number (n) 
are listed for each of the categorical variables. P-values are reported to determine 
statistical significance along with 95% confidence intervals. 
 As shown in tables 3 and 4, non-Hispanic black males and females had the 
highest percentages (49.9%, 53.8%, 58.4% and 55.3%) for weight control and increasing 
physical activity and were statistically significantly higher than non-Hispanic white and 
Mexican Americans. Non-Hispanic black males had the highest percentage of 46.0% for 
reducing fat or calories in diet. However, it was not statistically significantly higher 
compared to non-Hispanic white and Mexican American males. Mexican American 
females had the highest percentage for reducing fat or calories in diet at 56.3% which 
also was not statistically significantly higher compared to Non-Hispanic white and Non-
Hispanic black females.For past year lifestyle changes of weight control and increasing 
physical activity, non-Hispanic white males had the highest percentages, 18.6% and 
23.5%, respectively, but were not statistically significantly higher than non-Hispanic 
black and Mexican American males. Non-Hispanic black females had the highest 
percentages (32.2%, 39.6%, 35.9% and 40.2%) for past year weight control, increasing 
physical activity, reducing fat/calories in diet and diabetes risk reduction behavior. All 
were statistically significantly higher, except diabetes risk reduction behavior, than non-
Hispanic white and Mexican American females. Mexican American males had the 
highest percentage of 20.8% for reducing fat/calories in diet. However it was not 
statistically significantly higher compared to non-Hispanic white and black males. Lastly, 
31.7% of non-Hispanic black males were engaging in diabetes risk reduction behavior 
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which was statistically significantly higher than Mexican American and non-Hispanic 
white males. 
4c. Univariate Analysis 
 Univariate analysis was conducted separately for males and females to determine 
the association between each of the examined independent variables and the adoption of 
diabetes risk reduction behavior. Results of the univariate analysis are shown in Tables 5 
and 6. The magnitude of association between each of the independent variables, which 
include awareness of diabetes risk, age, education, annual family income, BMI, 
hypertension, mean systolic blood pressure, mean diastolic blood pressure, total 
cholesterol, LDL, HDL, and triglycerides, are quantified using the odds ratio from the 
logistic regression models. The 95% confidence intervals are also shown for each of the 
listed odds ratio to determine statistical significance. 
 As shown in table 5, there is an increase in the adoption of diabetes risk reduction 
behavior for males who are aware of their risk for diabetes. For example, Mexican 
American males show higher odds for the adoption of diabetes risk reduction behavior 
compared to non-Hispanic white males and non-Hispanic black males. Females also 
showed a similar association between the awareness of diabetes risk and adoption of 
diabetes risk reduction behavior. An increase in age was associated with the adoption of 
diabetes risk reduction behavior for non-Hispanic white males. However, there was not a 
statisticallysignificant association for non-Hispanic black males and Mexican American 
males, non-Hispanic black females, non-Hispanic white females and Mexican American 
females. An increase in the level of education and annual family income were associated 
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with increased odds of adoption of diabetes risk reduction behavior among non-Hispanic 
white, non-Hispanic black and Mexican American males and females. An increase in 
BMI was also associated with increased odds of adoption of diabetes risk reduction 
behavior for non-Hispanic white males, non-Hispanic white females,non-Hispanic black 
females and Mexican American males and females . However, non-Hispanic black males 
showed a slight decrease in odds of adoption of diabetes risk reduction behavior for BMI. 
In addition, as males and females discovered that they had hypertension there was an 
increase in odds of adopting diabetes risk reduction behavior. The association of 
hypertension and adoption of diabetes risk reduction behavior was higher in non-
Hispanic white males compared to non-Hispanic black and Mexican American males. In 
females, non-Hispanic black females demonstrated a stronger association between 
hypertension and adoption of diabetes risk reduction behavior compared to non-Hispanic 
white and Mexican American females. Mean systolic blood pressure, mean diastolic 
blood pressure, total cholesterol, LDL, HDL, and triglycerides were not statistically 
significantly associated with the adoption of diabetes risk reduction behavior among all 
three ethnicities for males. Females showed a similar association between mean systolic 
blood pressure,, total cholesterol, LDL, HDL and triglycerides. However, diastolic blood 
pressure was associated with an increase in odds of adoption of diabetes risk reduction 
behavior.  
4d. Multivariate Analysis 
Multivariate logistic regression was performed to determine whether the 
associations in the univariate model were not dependent of other covariates. Table 7,8 
and 9 show the multivariate analyses for both males and females. Table 7 included 
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ethnicity and gender in the analyses to determine whether they were significantly 
associated with diabetes risk reduction behavior. As a result, both of the variables, 
ethnicity and gender, were significant, which allowed for further stratification according 
to those variables. Awareness of diabetes risk, education, annual family income and BMI 
were also statistically significantly associated with diabetes risk reduction behavior while 
adjusting for other variables. Age, hypertension, mean systolic blood pressure, mean 
diastolic blood pressure, total cholesterol, LDL, HDL and triglycerides did not show 
statistical significance and did not have an increase in odds of association with diabetes 
risk reduction behavior. Table 8 and 9 further stratifies table 7 and shows the break down 
of the independent variables according to gender and ethnicity. As shown in Table 8 and 
9, there is an increase in the odds of association between the awareness of one’s diabetes 
risk with the adoption of diabetes risk reduction behavior in both males and females. 
However, non-Hispanic black, non-Hispanic white and Mexican American males and 
females did not show statistical significance between the awareness of one’s diabetes risk 
and the adoption of diabetes risk reduction behavior. Association of age and the adoption 
of diabetes risk reduction behavior was higher among Mexican American males and 
females compared to non-Hispanic white and black males and females. Education and 
annual family income both showed an increase in the odds of association for the adoption 
of diabetes risk reduction behavior, however they are not statistically significant in both 
males and females. BMI is the only statistically significant variable adjusting for the 
other variables and shows an increase in odds of adoption of diabetes risk reduction 
behavior in both males and females Non-Hispanic black females and non-Hispanic white 
males showed a higher association between BMI and the adoption of diabetes risk 
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reduction behavior. Age, hypertension, mean systolic blood pressure, mean diastolic 
blood pressure, total cholesterol, LDL, HDL, and triglycerides do not show statistical 
significance among both males and females. 
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CHAPTER V 
DISCUSSION AND CONCLUSION 
5a. Discussion 
 Identification of the awareness of one’s diabetes risk and prediabetes status is 
potentially important for the initiation and implementation of several prevention and 
structured lifestyle interventions. Adoption of lifestyle modifications such as weight 
control, physical activity, and reduction in fat/calories in one’s diet may improve the 
health of those high-risk individuals, but particularly among those groups of individuals 
that reported these behaviors less frequently; which include men, non-Hispanic blacks, 
and normal weight people (Geiss et al., 2010). In addition, clinical trials provide strong 
and consistent evidence that type 2 diabetes can be prevented or delayed in high-risk 
adults with prediabetes through these structured lifestyle modifications (Geiss et al., 
2010). Therefore, the knowledge and discovery of what lifestyle changes adults with 
prediabetes are currently making and factors associated with these changes may be useful 
in planning effective lifestyle interventions. Although there have been studies that have 
identified those who are at risk for diabetes and prediabetes and examined those 
individuals that engage in diabetes risk reduction behaviors (ie. weight control, physical 
activity and diet),  few of them have looked at specific ethnic groups and the association 
of the awareness of diabetes risk and other risk factors involved in the adoption of 
diabetes risk reduction behavior. This study is unique and particularly important for the 
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development of interventions and lifestyle changes specific for those individuals, ethnic 
groups and genders that are at a high risk for development of type 2 diabetes. 
 The objective of this study was to use nationally representative data to identify 
whether one’s awareness of diabetes risk is associated with the adoption of diabetes risk 
reduction behavior (combination of weight control, physical activity and reduction in 
fat/calories in diet) and whether this relationship would vary by gender and ethnicity. 
Other risk factors such as age, education, annual family income, BMI, hypertension, 
mean systolic blood pressure, mean diastolic blood pressure, total cholesterol, LDL, 
HDL, and triglycerides were also examined. 
 Results of the study indicated that the awareness of one’s diabetes risk is 
associated with the adoption of diabetes risk reduction behavior. One study by Geiss et al. 
examined lifestyle changes consistent with reducing diabetes risk and factors associated 
with their adoption among adults with prediabetes. The study by Geiss et al. is similar to 
the present study, however, it was not able to examine how awareness of prediabetes was 
associated with reduction behaviors due to the small number of people who were aware 
of prediabetes (2010). In addition, the methodology, the analyses, study variables, and the 
sample population that met the eligibility criteria of the study by Geiss et al. also differed 
compared to this study. For example, Geiss et al. modeled the three risk reduction 
behaviors separately in their multiple logistic regression analysis instead of combining 
them into a single variable and they defined prediabetes differently from the current 
study. Unlike the Geiss et al. study, the present study stratified the analyses according to 
gender and ethnicity. In this study it was found that non-Hispanic black males and 
females were more likely to engage in diabetes risk reduction behaviors. However, 
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stratification according to race and gender indicated that Mexican American males and 
females, who were aware of their diabetes risk, were more likely to adopt diabetes risk 
reduction behavior compared to non-Hispanic white and blacks. An increase in the level 
of education, annual family income and BMI was also associated with the adoption of 
diabetes risk reduction behavior. Specifically, results indicated that non-Hispanic black 
females and Mexican American males were more likely to adopt diabetes risk reduction 
behavior if they had higher levels of education. Similarly, Geiss et al. found that those 
with less than high school education were least likely to report increasing physical 
activity in the past year, which is consistent with this study that those with a lower level 
of education are least likely to engage in diabetes risk reduction behavior.  
This study is also consistent with the finding by Geiss et al. that women were 
more likely than men to engage in diabetes risk reduction behavior. In regards to annual 
family income, Mexican American males and females reported having a higher annual 
family income in association with adoption of diabetes risk reduction behavior. It was 
also found that non-Hispanic black females and non-Hispanic white males had higher 
BMI which in turn was associated with adoption of diabetes risk reduction behavior. This 
is consistent with the Geiss et al. finding that, generally, those of normal BMI are less 
likely than overweight or obese adults to report engaging in each diabetes risk reduction 
activity (2010). Geiss et al. also reported that race/ethnicity was associated with reports 
of two of the diabetes risk reduction activities-trying to control or lose weight and 
reducing fat and calories-with non-Hispanic whites being more likely than other race and 
ethnic groups to report these behaviors (2010 ). Another study by Tuomilehto et al. found 
that many subjects with impaired glucose tolerance are both obese and inactive and 
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therefore  it might be expected to find a dose-response relation between the correction of 
these multiple risk factors and reductions in the risk of diabetes (2001). Counseling those 
individuals with a higher BMI about effective diabetes risk reduction practices and 
behaviors which may include physical activity, exercise, and diet may reduce their 
diabetes risk. 
Results from the multivariate analyses of this study showed that an increase in the 
unit or levels of hypertension, mean systolic blood pressure, mean diastolic blood 
pressure, total cholesterol, LDL, HDL, and triglyceride levels lead to a higher probability 
of  the adoption of diabetes risk reduction behavior. However, none of the variables 
showed a significant association. The analyses by Geiss et al., was not able to determine 
the association between each of the mentioned variables and the adoption of diabetes risk 
reduction behavior. However, the analyses showed that compared to people without 
prediabetes, adults with prediabetes were more likely to have higher levels of well-known 
cardiovascular disease risk factors, including higher mean weight, waist circumference, 
systolic blood pressure, and triglyceride levels as well as a higher prevalence of 
hypertension (Geiss et al.., 2010). Therefore, the present study and the study by Geiss et 
al. indicate that efficient identification of prediabetes or the awareness of one’s diabetes 
risk may lead to opportunities for better cardiovascular risk factor management along 
with initiation of preventive behaviors to lower diabetes risk (Geiss et al., 2010). 
CDC provided the first nationally representative estimates of the prevalence of 
self-reported prediabetes in the U.S. adult population and the first estimates of the 
prevalence of risk reduction activities among adults who had been told they had 
prediabetes from the 2006 National Health Interview Survey (CDC, 2008). This report 
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differed from the present study in that it also, like the study by Geiss et al., did not show 
the association between the awareness of diabetes risk and the adoption of diabetes risk 
reduction behavior in the presence of other risk factors. However, results of the study 
indicated that among those who had been told they had prediabetes, 68% had tried to lose 
or control weight, 55% had increased physical activity or exercise, 60% had reduced 
dietary fat or calories, and 42% had engaged in all three activities (CDC, 2008). The 
diabetes risk reduction behavior characteristics of the present study indicated that about 
40% of U.S .female adults and about 25% of U.S. male adults engaged in diabetes risk 
reduction behavior (combination of weight control, physical activity and diet).  
5b. Strengths and Limitations 
 The major strength of the present study is the use of NHANES 2007-2008 data. 
NHANES is unique in that it is representative of the U.S. population and that the data 
could be generalized to the whole U.S. population. In addition, the biological risk factor 
data were collected using standardized laboratory and physical measurements. Personnel 
were also systematically trained to collect laboratory data and physical measurements. 
However, there are also a number of limitations. First, because of the cross-sectional 
nature of the data, only associations, not causality, can be examined. The cross-sectional 
data only provides a snapshot of the population, at that one point in time and cannot 
determine the cause-effect relationship for that specific time period. Prospective studies 
of interventions and policies to promote and maintain healthy lifestyles are needed (Geiss 
et al., 2010). Second, the data on variables such as age, education, annual family income 
and risk reduction behaviors were based on self-reports and, thus may be influenced by 
the accuracy of recall, self-report bias and social desirability bias. Misclassification bias 
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may have occurred when participants were classified into different categories. Third, the 
study was restricted to certain variables and could have included the variables family 
history and physician advice for the identification of those who have prediabetes and 
those that are influenced by their physicians to engage in diabetes risk reduction 
activities. Fourth, the analyses presented are not weighted and did not account for the 
complex sampling design used with NHANES. Finally, a number of other important 
questions were not addressed by the current study including why and when physicians 
provided lifestyle counseling, and whether and what type of counseling is effective 
(Geiss et al., 2010).  
5c. Clinical and Public Health Implications 
U.S. adults with prediabetes and who are aware of their diabetes risk may make 
behavioral and lifestyle changes to reduce their diabetes risk. However, it is important 
that health care providers, physicians and other public health professionals provide advice 
and interventions to increase the promotion of risk reduction behaviors and healthy 
lifestyles as well as community-level programs that are evidence-based for those people 
at high risk for type 2 diabetes.  
The multivariate analyses of this study have indicated that Mexican Americans, 
who are aware of their diabetes risk, are more likely to adopt and engage in diabetes risk 
reduction behaviors. Therefore, it is important for physicians and health care providers to 
develop culturally and linguistically appropriate education materials for this particular 
ethnic group. This study also indicated that SES factors such as education and annual 
family income influence the adoption of diabetes risk reduction behaviors. Therefore, 
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effective population-based interventions that decrease obesity, diabetes risk and improve 
health behaviors should be implemented to reduce SES and racial/ethnic disparities. 
According to the study by Tuomilehto et al., the reasonably low dropout rate in their 
study indicated that subjects with impaired glucose tolerance are willing and able to 
participate in a demanding intervention prevention program if it is made available to 
them (Tuomilehto et al., 2001). Therefore, provision of readily available intervention and 
diabetes prevention programs is important to reduce an individual’s risk for diabetes and 
to reverse U.S national trends in diabetes incidence. Finally, more efficient identification 
and awareness of risk on the part of patients, their providers, healthcare systems, and 
health payers are likely to be a key first step to implementing these changes (Geiss et al., 
2010). 
5d. Conclusion 
 Diabetes is a major health problem in both men and women and in the three main 
racial ethnic groups (non-Hispanic white, non-Hispanic black and Mexican Americans) 
in the U.S. Using NHANES 2007-2008 data, the results of this study indicate that 
prediabetes and the awareness of one’s diabetes risk, in the presence of other risk factors, 
may influence or encourage one’s decision in the adoption and participation in diabetes 
risk reduction behaviors. This study also provides useful insights for health care 
providers and public health professionals who are developing health promotion and 
prevention interventions to address prediabetes before it develops into type 2 diabetes. 
Although it has been demonstrated that behavioral and chemotherapeutic interventions 
can delay or prevent type 2 diabetes, these interventions have not been successfully 
implemented in large-scale clinical or population-based programs (Robbins et al., 2005). 
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The examination of the three ethnic groups andmales and females separately may provide 
information useful in the development of interventions specifically targeted for those 
groups that are aware of their health risk and are most likely to adopt diabetes risk 
reduction behaviors. In addition, the many risk factors, such as education, family income 
and BMI, that may affect one’s engagement in diabetes risk reduction activities, may also 
be addressed to eliminate or reduce gender, racial and SES disparities. Prevention efforts 
targeted towards the specifically mentioned gender and ethnic groups may reduce the 
overall increasing prevalence of diabetes, reduce disparities and may have a positive 
impact on the overall health of the U.S. population. 
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Table1 . Demographic and biological characteristics of U.S. male adults ages 20 and above 
     Mexican Americans  Non-Hispanic Whites      Non-Hispanic blacks   p-value 
Sociodemographic       (n) % or mean ± SD     (n) % or mean± SD             (n) % or mean± SD 
Characteristics 
Age                   42.3± 15.6a                         51.4± 18.7b                      46.5± 16.8c   <0.001 
Education  
< High School              (139) 33.7a              (75) 6.6b                       (38) 8.2c 
   High School                 (175) 42.4a              (447) 39.5b                       (224) 48.6c   <0.001 
   College                 (99) 24.0a              (610) 53.9b                       (199) 43.2c 
Annual Family Income  
    Less than $20,000       (114) 29.8a              (233) 21.1b                       (107) 24.3c   
    $20,000-$74,999         (220) 57.4a              (562) 50.9b                       (242) 54.9c   < 0.001 
    $75,000 +                 (49) 12.8a              (309) 28.0b                       (92) 20.9c 
Body Measures 
    BMI     
      Normal                  (90) 23.7a              (322) 29.7b                       (162) 37.3a 
      Overweight     (164) 43.2a              (439) 40.5b                       (136) 31.3a   < 0.001 
      Obese                        (126) 33.2a              (322) 29.7b                       (136) 31.3a 
Clinical Characteristics 
    Hypertension 
        Yes                  (101) 24.5a              (461) 40.7a                       (185) 40.1b 
                <0.001 
        No       (312) 75.5a              (672) 59.3a                       (276) 59.9b   
Mean Systolic BP             123.4± 14.2a                      125.1± 15.9 a,b                                 126.6± 19.3b     0.032 
Mean Diastolic BP            72± 11.5a                           71.8± 12.4a,b                                    73.9± 12.2b      0.016 
Total Cholesterol              200.7± 41.1a              193.6± 41.0a                                    193.4± 40.6b     0.011 
LDL                               119.8± 30.7a              116.6± 35.0a                                    115.0± 37.7a                           0.425  
HDL                   45.4± 11.9a                          46.6± 13.0a                                      53.8± 16.6b   < 0.001 
Triglycerides                  151.4± 88.5a                       148.2± 126.6b                                  101.1±61.4b   <0.001 
*Pairwise comparisons were done using Tukey posthoc tests and Chi-square tests for continuous and categorical variables. Values with different 
superscripts differ at p<0.05 levels 
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Table 2. Demographic and biological characteristics of U.S. female adults ages 20 and above 
  Mexican Americans                        Non-Hispanic Whites                                 Non-Hispanic Blacks  p-value 
Sociodemographic  (n) % or mean±SD               (n) % or mean±SD                                    (n) % or mean±SD 
Characteristics 
Age         42.6± 15.8a                     52.2± 18.3b                                        46.5± 17.1c   < 0.001 
Education 
< High school       (106) 24.9a                      (53) 4.6a                                         (25) 5.2b 
   High school       (184) 43.2a                    (469) 40.3a                             (218) 44.9b   < 0.001 
   College       (136) 31.9a                    (641) 55.1a                             (242) 49.9b 
Annual Family Income 
   Less than $20,000  (110) 27.0a         (287) 25.6b                                                  (142) 30.3b 
   $20,000-$74,999    (241) 59.1a                           (559) 49.9b                                                  (243) 51.9b   < 0.001 
   $75,000 +               (57) 14.0a         (275) 24.5b                                                   (83) 17.7b 
Body Measures 
  BMI 
    Normal           (99) 24.1a         (435) 39.3b                                                   (119) 25.6b 
    Overweight          (141) 34.3a         (346) 31.3b                              (143) 30.8b   < 0.001 
Obese                   (171) 41.6a                             (326) 29.4b                              (203) 43.7b 
Clinical Characteristics 
Hypertension 
     Yes             (97) 22.7a         (453) 39.0b                               (217) 44.7c 
                  <0.001 
      No         (331) 77.3a        (710) 61.0b                                         (268) 55.3c  
Mean Systolic BP   117.0± 17.9a                   122.1± 18.7b                                                 123.5± 20.2b    < 0.001 
Mean Diastolic BP  66.8± 12.3a                           69.3± 11.6b                                                   70.0± 12.5b     < 0.001 
Total Cholesterol    197.4± 39.6a                   205.3± 41.0a                                         195.2± 41.7b     < 0.001 
LDL          117.1± 33.5a                          119.3± 34.2a,b                                                111.6± 35.8b     < 0.001 
HDL                        52.8± 14.2a                   58.4± 17.3b                                          62.5± 17.8c      < 0.001 
Triglycerides          131± 83.7a                   122.9± 74.5b                                                  86.1± 61.3b      < 0.001 
 
*Pairwise comparisons were done using Tukey post hoc tests and Chi square tests for continuous and categorical variables. Values with different 
superscripts differ at p<0.05 levels 
61	  
	  
	  
Table 3: Diabetes Risk Reduction behavior characteristics of U.S male adults above 20 
   Non-Hispanic Whites Non-Hispanic Blacks     Mexican Americans      P-value 
                 % (n)                  % (n)                                      % (n)  
On Going Lifestyle Changes 
Controlling Weight 
 No  55.3 (627)a         50.1 (231)a                           64.2 (265)b < 0.001 
 Yes                   44.7 (506)a         49.9 (230)a    35.8 (148)b 
Increasing Physical Activity 
 No  60.3 (683)a         46.2 (213)b    61.0 (252)a < 0.001 
 Yes  39.7 (450)a         53.8 (248)b   39.0 (161)a 
Reducing Fat or Calories in Diet 
 No  59.7 (676)a         54.0 (249)b   59.3 (245)a,b    0.100 
 Yes  40.3 (456)a         46.0 (212)b   40.7 (168)a,b 
Past Year Lifestyle Changes 
Controlling Weight 
 No  81.4 (922)a         85.5 (394)a   83.1 (343)a    0.144 
 Yes  18.6 (211)a         14.5 (67)a   16.9 (70)a 
Increasing Physical Activity 
 No  76.5 (866)a         80.9 (373)a   79.7 (329)a    0.110 
 Yes  23.5 (266)a         19.1 (88)a   20.3 (84)a 
Reducing fat/calories in diet 
 No  79.6 (901)a         80.7 (372)a   79.2 (327)a    0.837 
 Yes  20.4 (231)a         19.3 (89)a   20.8 (86)a 
*Diabetes Risk Reduction Behavior 
 No  75.2 (852)a         68.3 (315)b   76.0 (314)a    0.009 
 Yes  248 (281)a         31.7 (146)b   24.0 (99)a 
Diabetes risk reduction behavior was defined as a combination of ongoing weight control, physical 
activity and reduction in fat/calories intake. Pairwise comparisons were done using Chi-square tests for 
categorical variables. Values with different superscript (a,b,c) differ at a p-value< 0.05. Boldface 
indicates significance (p<0.05) 
62	  
	  
	  
Table 4. Diabetes Risk Reduction behavior characteristics of U.S. female adults above 20 
   Non-Hispanic Whites Non-Hispanic Blacks Mexican Americans P-value 
    % (n)   % (n)                  % (n)  
On Going Lifestyle Changes 
Controlling Weight 
 No  47.9 (557)a  41.6 (202)b         52.1 (223)a  0.006 
 Yes  52.1 (606)a  58.4 (283)b         47.9 (205)a 
Increasing Physical Activity 
 No  52.0 (604)a  44.7 (217)b         52.6 (225)a  0.017 
 Yes  48.0 (558)a  55.3 (268)b         47.4 (203)a 
Reducing Fat or Calories in Diet 
 No  48.5 (564)a  43.9 (213)a         43.7 (187)a  0.105  
 Yes   51.5 (599)a  56.1 (272)a         56.3 (241)a 
Past Year Lifestyle Changes 
Controlling Weight 
 No  80.7 (938)a  67.8 (329)b         75.2 (322)c  < 0.001 
 Yes  19.3 (225)a  32.2 (156)b         24.8 (106)c 
Increasing Physical Activity 
 No  70.8 (822)a  60.4 (293)b         67.1 (287)a  < 0.001 
 Yes  29.2 (339)a  39.6 (192)b         32.9 (141)a 
Reducing fat/calories in diet 
 No  78.2 (910)a  64.1 (311)b         69.9 (299)a,b < 0.001 
 Yes  21.8 (253)a  35.9 (174)b         30.1 (129)a,b 
*Diabetes Risk Reduction Behavior 
 No  65.1 (757)a  59.8 (290)b         65.7 (281)a,b   0.087 
 Yes   34.9 (406)a  40.2 (195)b         34.3 (147)a,b 
Diabetes risk reduction behavior was defined as a combination of ongoing weight control, physical 
activity and reduction in fat/calories intake. Pairwise comparisons were done using Chi-square tests for 
categorical variables. Values with different superscripts (a,b,c) differ at p-value < 0.05. Boldface indicates 
significance (p<0.05) 
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Table 5. Association between awareness of one’s diabetes risk with adoption of diabetes risk reduction behavior in U.S male adults 
ages 20 and above by ethnicity. 
 
Characteristics Non-Hispanic Whites  Non-Hispanic Blacks  Mexican Americans 
   OR (95% CI)    OR (95% CI)    OR (95% CI) 
Aware of Diabetes Risk 
  Nor    
  Yes   2.373 (1.622-3.473)   2.031 (1.004-4.107)   2.505 (1.285-4.885) 
Age   1.009 (1.001-1.016)   0.998 (0.986-1.009)   1.009 (0.995-1.024) 
Education 
< High schoolr 
   High school  0.828 (0.454-1.513)   2.817 (1.054-7.528)   1.352 (0.760-2.406) 
   College  1.580 (0.886-2.820)   3.907 (1.461-10.447)   3.278 (1.795-5.987) 
Annual Family Income 
Less than $20,000r 
$20,000-$74,999 1.583 (1.075-2.332)   1.087 (0.657-1.799)   1.327 (0.759-2.320) 
$75,000 +  2.079 (1.373-3.148)   1.974 (1.095-3.561)   3.136 (1.508-6.524) 
BMI 
  Normalr 
  Overweight  3.486 (2.312-5.257)   3.608 (2.112-6.163)   1.777 (0.923-3.419) 
  Obese   4.518 (2.959-6.896)   3.395 (1.985-5.807)   1.848 (0.936-3.646) 
Hypertension 
  Nor 
  Yes   1.642 (1.252-2.155)   1.152 (0.773-1.717)   1.302 (0.782-2.168) 
Mean Systolic BP 0.999 (0.990-1.008)   0.987 (0.975-0.999)   0.996 (0.978-1.014) 
Mean Diastolic BP 1.000 (0.989-1.011)   1.004 (0.986-1.022)   1.014 (0.992-1.037) 
Total Cholesterol 0.997 (0.994-1.001)   1.004 (0.999-1.009)   1.000 (0.994-1.006) 
LDL   1.000 (0.994-1.005)   0.999 (0.991-1.007)   1.004 (0.992-1.015) 
HDL   0.995 (0.984-1.006)   0.992 (0.979-1.005)   1.002 (0.982-1.022) 
Triglycerides  1.001 (0.999-1.002)   0.999 (0.994-1.004)   0.999 (0.995-1.003) 
* P< 0.05; r Reference group; Diabetes risk reduction behavior was defined as a combination of ongoing weight control, physical activity and reduction in 
fat or calories intake. 
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Table 6. Association between awareness of one’s diabetes risk with adoption of diabetes risk reduction behavior in U.S. female adults 
ages 20 and above by ethnicity. 
 
Characteristics Non-Hispanic Whites   Non-Hispanic Blacks   Mexican Americans 
   OR  (95% CI)    OR (95% CI)    OR (95% CI) 
Aware of Diabetes Risk 
  Nor 
  Yes   2.081 (1.508-2.871)   2.117 (1.306-3.429)   3.459 (2.058-5.814) 
Age   0.997 (0.991-1.004)   1.000 (0.990-1.011)   1.011 (0.999-1.024) 
Education 
< High schoolr 
   High school  1.003 (0.534-1.884)   1.852 (0.667-5.140)   1.175 (0.702-1.967) 
   College  1.707 (0.920-3.166)   4.000 (1.454-11.003)   1.477 (0.861-2.532) 
Annual Family Income 
Less than $20,000r 
$20,000-$74,999 1.474 (1.072-2.026)   1.301 (0.844-2.005)   1.159 (0.712-1.889) 
$75,000 +  2.667 (1.868-3.806)   2.435 (1.397-4.242)   2.100 (1.085-4.066) 
BMI 
  Normalr 
  Overweight  1.664 (1.233-2.245)   4.010 (2.239-7.182)   1.760 (0.984-3.147) 
  Obese   1.707 (1.260-2.312)   5.409 (3.109-9.412)   2.129 (1.218-3.721) 
Hypertension 
  Nor    
  Yes   1.207 (0.943-1.543)   1.612 (1.118-2.324)   1.469 (0.923-2.339) 
Mean Systolic BP 0.999 (0.992-1.007)   1.005 (0.995-1.015)   1.008 (0.996-1.020) 
Mean Diastolic BP 1.017 (1.005-1.029)   1.027 (1.009-1.044)   1.009 (0.991-1.027) 
Total Cholesterol 0.999 (0.996-1.002)   0.998 (0.993-1.003)   1.001 (0.996-1.006) 
LDL   0.995 (0.989-1.000)   0.994 (0.986-1.003)   0.996 (0.986-1.006) 
HDL   0.998 (0.991-1.006)   0.993 (0.982-1.005)   0.987 (0.972-1.002) 
Triglycerides  1.002 (0.999-1.004)   1.005 (0.999-1.010)   1.001 (0.998-1.005) 
 
* P<0.05; rReference group; Diabetes risk reduction behavior was defined as a combination of ongoing weight control, physical activity and reduction in 
fat or calories intake. 
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Table 7. Association between awareness of one’s diabetes risk with adoption of diabetes risk reduction behavior for U.S male and female adults ages 20 and 
above. (Multivariate Analysis) 
 
Characteristics      OR      95% Confidence Interval 
Aware of Diabetes Risk 
  Nor 
  Yes       1.734      1.217-2.470 
Age       1.006      0.997-1.015 
Gender 
maler 
female       1.405      1.084-1.821 
Race 
  Non-Hispanic whitesr 
  Non-Hispanic blacks     1.459      1.070-1.989 
  Mexican Americans     1.108      0.791-1.551 
Education 
< High schoolr 
  High school      1.127      0.694-1.832 
  College      1.833      1.118-3.004 
Annual Family Income 
  Less than $20,000r 
  $20,000-$74,999     1.213      0.886-1.661 
  $75,000 +      1.920      1.319-2.794 
BMI 
  Normalr 
  Overweight      2.049      1.511-2.780 
  Obese       2.295      1.649-3.195 
Hypertension 
  Nor 
  Yes       1.060      0.771-1.457 
Mean Systolic BP     0.995      0.986-1.004 
Mean Diastolic BP     1.010      0.999-1.022 
Total Cholesterol                    0.838      0.545-1.288 
LDL       1.189      0.773-1.827 
HDL       1.188      0.773-1.826 
Triglycerides      1.035      0.950-1.128 
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Table 8: Association between awareness of one’s diabetes risk with adoption of diabetes risk reduction behavior for U.S. male adults ages 20 and above 
(Multivariate analysis). 
 
Characteristics  Non-Hispanic Whites   Non-Hispanic Blacks   Mexican Americans 
   OR (95% CI)    OR (95% CI)    OR (95% CI) 
Aware of Diabetes Risk 
   Nor 
   Yes   1.872 (0.910-3.850)   1.775 (0.369-8.532)   2.496 (0.792-7.868) 
Age   1.001 (0.986-1.017)   1.000 (0.972-1.029)   1.038 (1.001-1.077) 
Education 
< High schoolr 
  High school  0.906 (0.284-2.885)   1.812 (0.287-11.442)   1.698 (0.543-5.312) 
  College  1.815 (0.569-5.791)   2.234 (0.357-13.963)   2.419 (0.699-8.377) 
Annual Family Income 
  Less than $20,000r 
  $20,000-$74,999 1.029 (0.523-2.025)   0.699 (0.272-1.795)   1.426 (0.494-4.121) 
  $75,000+  1.212 (0.584-2.515)   0.697 (0.219-2.226)   1.341 (0.283-6.364) 
BMI 
  Normalr 
  Overweight  2.316 (1.240-4.328)   3.626 (1.429-9.200)   1.660 (0.517-5.328) 
  Obese   3.592 (1.807-7.142)   2.524 (0.882-7.225)   1.254 (0.315-4.992) 
Hypertension 
  Nor 
  Yes   1.185 (0.675-2.082)   1.221 (0.446-3.343)   1.314 (0.377-4.579) 
Mean Systolic BP 1.002 (0.985-1.020)   0.970 (0.940-1.001)   0.997 (0.958-1.038) 
Mean Diastolic BP 1.005 (0.986-1.025)   1.022 (0.983-1.063)   1.004 (0.960-1.049) 
Total Cholesterol  1.220 (0.537-2.772)   0.404 (0.104-1.574)   1.389 (0.326-5.923) 
LDL   0.818 (0.360-1.859)   2.471 (0.634-9.625)   0.720 (0.169-3.071) 
HDL   0.818 (0.360-1.859)   2.477 (0.635-9.668)   0.712 (0.167-3.037) 
Triglycerides  0.959 (0.813-1.130)   1.198 (0.912-1.573)   0.934 (0.698-1.249) 
 P<0.05; rReference Group. Diabetes risk reduction behavior was defined as a combination of ongoing weight control, physical activity and reduction in fat or 
calories intake. 
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Table 9: Association between awareness of one’s diabetes  risk with adoption of diabetes risk reduction behavior for U.S. female adults ages 20 and above. 
(Multivariate analysis). 
 
Characteristics  Non-Hispanic Whites   Non-Hispanic Blacks   Mexican Americans 
   OR (95% CI)    OR (95% CI)    OR (95% CI) 
Aware of Diabetes Risk 
  Nor 
  Yes   1.687 (0.897-3.171)   1.501 (0.537-4.195)   2.830 (0.917-8.736) 
Age   1.003 (0.985-1.020)   1.012 (0.981-1.045)   1.012 (0.977-1.048) 
Education 
< High schoolr  
  High school  1.014 (0.301-3.411)   4.811 (0.340-68.057)   0.866 (0.269-2.781) 
  College  1.800 (0.539-6.010)   8.549 (0.570-128.256)   1.039 (0.317-3.406) 
Annual Family Income 
  Less than $20,000r 
  $20,000-$74,999 1.959 (1.059-3.623)   1.005 (0.414-2.441)   1.307 (0.445-3.833) 
  $75,000 +  4.041 (1.999-8.169)   1.757 (0.536-5.762)   7.297 (1.428-37.288) 
BMI 
  Normalr 
  Overweight  1.455 (0.843-2.512)   5.898 (2.003-17.362)   1.895 (0.573-6.267) 
  Obese   1.690 (0.910-3.138)   4.296 (1.505-12.260)   2.425 (0.757-7.770) 
Hypertension 
  Nor 
  Yes   0.727 (0.396-1.336)   1.612 (0.569-4.569)   0.900 (0.216-3.743) 
Mean Systolic BP 1.010 (0.992-1.029)   0.988 (0.959-1.017)   0.988 (0.953-1.025) 
Mean Diastolic BP 1.001 (0.979-1.024)   1.010 (0.976-1.046)   1.022 (0.977-1.069) 
Total Cholesterol  0.698 (0.313-1.556)   0.461 (0.116-1.828)   1.495 (0.296-7.546) 
LDL   1.425 (0.639-3.178)   2.142 (0.541-8.483)   0.665 (0.132-3.354) 
HDL   1.424 (0.639-3.174)   2.126 (0.537-8.418)   0.652 (0.129-3.298) 
Triglycerides  1.076 (0.916-1.263)   1.169 (0.887-1.540)   0.922 (0.666-1.276) 
 
• P<0.05; rReference Group. Diabetes risk reduction behavior was defined as a combination of ongoing weight control, physical activity and reduction in 
fat or calories intak
